Buy GLP-1 (SMA) 30mg Research Peptide OnlineGLP-1 (SMA) 30mg Product Specifications & StorageGLP-1 Receptor Agonist Analog (SMA designation) is an engineered synthetic peptide based on the 31-amino-acid GLP-1 sequence with proprietary modifications designed to confer extended metabolic stability and sustained receptor activity in preclinical research applications. The SMA design represents a carefully optimized balance between proteolytic resistance and maintained receptor pharmacology in laboratory research systems.GLP-1 (SMA) Mechanism of ActionThe structural innovations conferring the SMA designation include both amino acid substitutions and covalent fatty acid conjugation. These modifications reduce susceptibility to multiple proteolytic pathways including DPP-4, neutral endopeptidase, and plasma exopeptidases, thereby extending the active pharmacological window in preclinical models. Despite these alterations, binding affinity and agonist efficacy at GLP-1 receptors remain fully preserved. In vitro receptor studies confirm that GLP-1 (SMA) maintains EC50 values comparable to native GLP-1 while exhibiting dramatically extended bioavailability in animal models.GLP-1 (SMA) Published Research SummaryPublished preclinical research by Holst et al. (2007) characterizes the integrated metabolic effects of sustained GLP-1R agonism. Animal studies document that extended-duration GLP-1 analog administration produces consistent suppression of hepatic glucose production, enhancement of glucose-stimulated insulin secretion, and deceleration of gastric emptying. Central nervous system research indicates that GLP-1R activation in hypothalamic nuclei contributes to energy expenditure modulation through separate neural mechanisms.GLP-1 (SMA) 30mg is formulated as lyophilized powder in research-grade containers. Reconstitute with sterile saline or bacteriostatic water; solutions maintain biological stability for 48 hours at 4°C. Unreconstituted powder demonstrates extended stability at 2-8°C storage temperature. Prevent freeze-thaw cycles and light exposure to preserve peptide integrity and maintain full biological activity.This product is designated exclusively for preclinical research and in vitro investigation. It is not approved for human consumption, clinical use, or therapeutic application. All research protocols must comply with institutional biosafety standards and applicable regulatory frameworks governing synthetic peptide research.
